A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

NCT04398524 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Carcinoma of the Oropharynx

Interventions

DRUG: ISA101b

Sponsor

ISA Pharmaceuticals

Collaborators

[object Object]